Bank of Maharashtra gets govt mandate to collect donations for PM CARES Fund; contributions to get I-T Act exemption
One can also remit contributions directly by electronic clearing system (ECS) to the designated savings bank account of Bank of Maharashtra.
Mumbai: State-owned Bank of Maharashtra (BoM) on Monday said the government has nominated it for collection of donations for the PM-CARES Fund to help fight COVID-19 pandemic.
The contributions can be made by cash, RTGS, NEFT, IMPS, cheques and demand drafts drawn in favour of the PM CARES Fund, the lender said in a release.
"One can also remit contributions directly by electronic clearing system (ECS) to the designated savings bank account of Bank of Maharashtra," the release said.
The contribution made for the fund is 100 percent exempted under Section 80G of the Income Tax Act.
Last week, Indian Overseas Bank said it has been nominated for collection of donations for PM-Cares Fund.
The Prime Minister''s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund) was set up on 28 March to raise money for combating the Covid-19 crisis and to provide relief to the affected.
Many corporates, defence personnel, employees of PSUs such as railways, sports persons and Bollywood personalities have announced their contribution to the PM-CARES Fund.
The pandemic has so far claimed 109 lives and the number of cases in the country climbed to 4,067 on Monday, according to the Union health ministry.
While the number of active COVID-19 cases stands at 3,666, as many as 291 people were cured and discharged, and one has migrated, the ministry stated. The total number of cases include 65 foreign nationals.
On this day: Important events that happened on 11 March in the past
The World Health Organization (WHO) had declared on 11 March 2020 that the COVID-19 outbreak was a pandemic
This is why Beijing's population has declined for 1st time in 2 decades
Beijing's population decline was in line with national trends, with China's population falling last year for the first time in six decades
COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.